Globus Medical Inc (GMED)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 124,302 | 537,868 | 397,274 | 278,308 | 75,462 |
| Depreciation Amortization | 69,856 | 302,954 | 226,988 | 148,957 | 72,360 |
| Income taxes - deferred | 7,962 | 18,625 | 525 | -41,236 | 509 |
| Accounts receivable | -13,399 | -52,182 | 11,971 | 20,395 | 22,603 |
| Accounts payable and accrued liabilities | 5,082 | 8,487 | -654 | -4,085 | -899 |
| Other Working Capital | -28,118 | -66,795 | -45,286 | -47,027 | 9,601 |
| Other Operating Activity | 36,679 | 4,490 | -85,958 | -100,147 | -2,336 |
| Operating Cash Flow | $202,364 | $753,447 | $504,860 | $255,165 | $177,300 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 8,243 | 179,488 | 174,238 | 174,238 | 174,238 |
| PPE Investments | -39,615 | -164,679 | -118,482 | -82,665 | -36,103 |
| Net Acquisitions | -4,909 | -252,546 | -252,546 | -252,546 | -5,000 |
| Purchase Of Investment | -146,393 | -107,531 | -37,109 | -1,750 | -1,750 |
| Purchase Sale Intangibles | N/A | -9,746 | -9,666 | -5,000 | N/A |
| Other Investing Activity | 0 | -9,746 | -9,666 | -5,000 | 0 |
| Investing Cash Flow | $-182,674 | $-355,014 | $-243,565 | $-167,723 | $131,385 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 25,961 | 89,757 | 26,999 | 15,920 | 11,223 |
| Common Stock Repurchased | 0 | -300,451 | -255,451 | -215,451 | -190,451 |
| Other Financing Activity | -7,764 | -468,466 | -463,923 | -460,802 | -456,168 |
| Financing Cash Flow | $18,197 | $-679,160 | $-692,375 | $-660,333 | $-635,396 |
| Exchange Rate Effect | -3,093 | 22,445 | 18,411 | 17,899 | 3,539 |
| Beginning Cash Position | 526,156 | 784,438 | 784,438 | 784,438 | 784,438 |
| End Cash Position | 560,950 | 526,156 | 371,769 | 229,446 | 461,266 |
| Net Cash Flow | $34,794 | $-258,282 | $-412,669 | $-554,992 | $-323,172 |
| Free Cash Flow | |||||
| Operating Cash Flow | 202,364 | 753,447 | 504,860 | 255,165 | 177,300 |
| Capital Expenditure | -39,615 | -164,679 | -118,482 | -82,665 | -36,103 |
| Free Cash Flow | 162,749 | 588,768 | 386,378 | 172,500 | 141,197 |